Abstract
Gastroesophageal reflux disease (GERD) is a widely prevalent gastrointestinal disorder, affecting ∼13.3% of the global population. There are shortages and limitations of current GERD treatment modalities, and complementary and alternative therapy (CAT) is a promising option to fill in the gap. Dietary and lifestyle modifications might play an important and complementary role in alleviating GERD symptoms. Traditional Chinese medicine and brain–gut behavior therapy, particularly transcutaneous electrical acustimulation and diaphragmatic breathing therapy were shown to be useful adjuncts or alternatives in treating GERD. CAT may help to relieve GERD symptoms, minimize medication dosage, and slow the demand for surgery. The aim of this review was to summarize the existing evidence of some common CATs in treating symptomatic GERD, including dietary modification, lifestyle change, traditional Chinese medicine, and brain–gut behavior therapy.
Keywords: GERD, complementary therapies, alternative therapies, lifestyle, traditional Chinese medicine, behavior intervention
Introduction
Gastroesophageal reflux disease (GERD) is a common chronic gastrointestinal disease that affects ∼13.3% of the population worldwide [1]. Owing to its high prevalence and chronic nature, GERD seriously affects patients’ quality of life and places a substantialeconomic burden on society [2, 3]. The annual costs related to GERD have reached $10 billion in the USA [4].
Conventional treatment modalities for GERD include pharmacologic therapy, and surgical and endoscopic interventions. Proton-pump inhibitors (PPIs) are the first-line treatment for GERD. However, up to 50% of patients reported persisting reflux symptoms despite PPI use [5]. In addition, long-term PPI use was associated with some adverse events, including bone fractures, kidney disease, infections, and gastric cancer [6]. Patients whoare refractory to medications or refuse long-term PPI use may undergo surgical or endoscopic interventions. At present, laparoscopic anti-reflux surgery (LARS) is the mainstay procedure in surgical options. However, a cohort study including 2,655 patients who underwent LARS reported that 17.7% of patients needed medications or secondary surgery after primary LARS, and 4% of patients suffered from post-operative complications [7]. Besides, the long-term efficacy of some emerging endoscopic procedures remains controversial [8, 9].
As limitations exist in pharmacologic and surgical treatment, there is growing interest in applying complementary and alternative therapy (CAT) to optimize GERD management. Dietary and lifestyle modifications can add as effective complements for GERD management [10]. Clinical guidelines suggested that avoidance of trigger foods and late meals, tobacco cessation, weight loss, and elevation of the bed head during sleep were beneficial for symptomatic GERD patients [11, 12]. However, the benefits of dietary pattern changes and physical exercise in GERD management are controversial. Besides, recent studies have shown traditional Chinese medicine (TCM) and brain–gut behavior therapy (BGBT) are effective in treating GERD, including transcutaneous electrical acustimulation (TEA) and diaphragmatic breathing therapy (DB), which may be promising adjuncts or alternatives for patients who fail medical and surgical therapies. This review summarizes the evidence of some common CATs in GERD management,including dietary and lifestyle modification, TCM, and BGBT.
Dietary modification
Several studies have indicated that unhealthy dietary structure or eating habits may be risk factors for GERD. Changes to dietary composition, eating habits, and diet patterns may lead to significant improvement in GERD symptoms (Table 1). In a clinical trialof 100 GERD patients, almost half of the patients reported symptom relief and PPI cessation after 2 weeks of dietary modification [13].
Table 1.
Prospective studies on dietary modification for symptomatic GERD
| Author | Study design | Subject | Intervention | Follow-up duration | Outcome |
|---|---|---|---|---|---|
| Pehl etal. (1999) [16] | Non-RCT | 12 healthy volunteers | Low-fat vs high-fat | – | No difference in the frequency of TLESRs, AET, and LESP was observed |
| Penagini etal. (1998) [15] | Non-RCT | 13 healthy volunteers and 14 GERD patients | High-fat vs balanced fat | – | No difference in esophageal acid exposure, the rate of reflux episodes, the rate of TLESRs, and basal LESP was observed |
| Fox etal. (2007) [17] | Non-RCT | 15 GERD patients | High-calorie vs low-calorie | – | High-calorie diet led to AET increase* |
| Pointer etal. (2016) [19] | Non-RCT | 144 obese women | High-fat/low-carbohydrate diet | 16 weeks | Total carbohydrates, total sugars, GERD symptoms, and medication usage decreased |
| Gu etal. (2022) [20] | RCT | 98 GERD patients | HTHS (n = 22) vs HTLS (n = 26) vs LTHS (n = 22) vs LTLS (n = 25) | 9 weeks | Reduction in simple sugar intake led to decrease in AET* and reflux episodes* and overall improvement of symptoms |
| Morozov etal. (2018) [22] | Non-RCT | 36 non-erosive gastroesophageal reflux disease patients | A fiber-enriched diet | 10 days | The frequency of heartburn***, the number of refluxes***, and minimal resting LESP decreased* |
| Aanen etal. (2006) [23] | Crossover RCT | 10 healthy volunteers | 5 g of NaCl vs placebo in capsules per day | 1 week | No difference in the number of reflux episodes and TLESRs was observed |
| Tosetti etal. (2021) [13] | Non-RCT | 100 GERD patients | Elimination of specific food items | 2 weeks | Overall improvement of symptoms was observed |
| Mehta etal. (2020) [29] | Cohort study | 48,308 women | – | 262,641 person-years | Coffee, tea, and soda consumption were risk factors for GERD |
| Patcharatrakul etal. (2021) [33] | Crossover RCT | 21 patients with overlapped GERD and irritable bowel syndrome | Wheat noodles vs rice noodles | – | Wheat ingestion increased heartburn and regurgitation scores* |
| Rivière etal. (2021) [32] | RCT | 31 refractory GERD patients | A low-FODMAP diet (n = 16) vs usual diet (n = 15) | 4 weeks | No difference in total Reflux Disease Questionnaire score, acid exposure, and reflux episodes was observed |
| Wu etal. (2014) [37] | Non-RCT | 15 GERD patients | High-volume vs low-volume | 2 consecutive days | A high-volume meal increased total number of reflux episodes*, AET*, and the number of reflux symptoms** |
| Wildi etal. (2004) [38] | Non-RCT | 20 healthy volunteers | Fast vs slow eating | 2 consecutive days | Rapid food intake increased the number of reflux episodes* |
| Bor etal. (2013) [39] | Non-RCT | 46 GERD patients | Fast vs slow eating | 2 consecutive days | No difference in the total number of refluxepisodes was observed |
| Valitova etal. (2013) [40] | Non-RCT | 60 GERD patients | Fast vs slow eating | 2 consecutive days | No difference in the number of reflux episodes and symptoms was observed |
| Piesman etal. (2007) [42] | Crossover RCT | 32 GERD patients | Early vs late meal | 2 consecutive days | An early meal decreased supine AET** and the number of nocturnal episodes* |
AET, acid exposure time; FODMAP, fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols; GERD, gastroesophageal reflux disease; HTHS, high total/high simple carbohydrate; HTLS, high total/low simple carbohydrate; LESP, lower esophageal sphincter pressure; LTHS, low total/high simple carbohydrate; LTLS, low total/low simple carbohydrate; RCT, randomized–controlled trial; TLESRs, transient lower esophageal sphincter relaxations.
P < 0.05;
P ≤ 0.01;
P ≤ 0.001.
Modification of dietary composition
Different nutrients have various impacts on GERD symptoms. A high-fat diet was considered as a trigger for GERD symptoms in observational studies [14]. However, studies showed that the percentage of postprandial reflux, frequency of transient lower esophageal sphincter relaxations (TLESRs), and acid exposure time (AET) were similar after a low-fat and high-fat meal among healthy volunteers and GERD patients [15, 16]. Therefore, instead of fat content, caloric density is assumed to be blamed for reflux. A study by Fox etal. [17] showed that patients exhibited more acid exposure on the high-calorie diet than the low-calorie one, regardless of fat content.
Although no correlation between total carbohydrate intake and GERD was found in population-based studies, a crossover placebo-controlled study showed that a high-carbohydrate diet might enhance colonic fermentation and worsen reflux symptoms [14, 18]. Besides, an interventional trial indicated that a low-carbohydrate diet was associated with the resolution of GERD symptoms and reduced medication use [19]. A randomized–controlled trial (RCT) including 98 symptomatic GERD patients also demonstrated that reduced intake of simple sugar could lead to a decrease in the AET, frequency, and severity of symptoms [20].
High dietary fiber intake can reduce the risk of GERD. Two large population-based studies have shown an inverse relationship between fiber intake and the risk of GERD [14, 21]. Morozov et al. [22] further showed a reduction in the frequency of heartburn and the number of reflux episodes after a 10-day fiber-enriched diet. On the contrary, high salt intake may be a risk factor for GERD. A dose-dependent relationship between higher salt intake and an increased risk of GERD was observed, but a placebo-controlled trial showed no impacts of high salt intake on the number of reflux episodes or TLESRs [21, 23]. The effects of high salt intake on GERD need further investigation.
Furthermore, some specific foods have been reported as risk factors for GERD, including meat (odds ratio [OR] 1.09, 95% confidenceinterval [CI] 1.04–1.14), fried foods (OR 3.01, 95% CI 1.52–6.20), spicy foods (OR 1.09, 95% CI 1.02–1.16), citrus fruit (OR 2.22, 95% CI 1.3–3.81), and sweets (OR 1.42, 95% CI 1.00–2.02), while some foods were protective factors, such as vegetables (OR 0.34, 95% CI 0.21–0.54) and vitamins (OR 0.46, 95% CI 0.24–0.90) [24, 25]. Restriction of trigger foods was beneficial to ameliorate symptoms [13]. However, data on the relationship between specific foods and GERD are inconclusive, further studies with larger sample sizes and long-term follow-up are needed.
As for beverages, several systematic studies have found no correlations between alcohol, coffee, tea, and soft drinks and GERD; however, most of the included studies were retrospective or cross-sectional [26–28]. Challenging these results, a prospective cohort study comprising 48,308 females suggested dose-dependent associations between the consumption of coffee, tea, and carbonated beverages and an increased risk of GERD [29]. A large population-based study conducted in Japan involving 19,864 adults also found a positive association between alcohol consumption and GERD symptoms [30]. The American College of Gastroenterology guideline on GERD management recommended that GERD patients should avoid trigger beverages [12], but the definitive associations between specific beverages and GERD remained to be explored.
In summary, avoidance of trigger food, including specific nutrients, foods, and beverages, is recommended in GERD management. A low-calorie, low-carbohydrate, fiber-enriched diet may also be recommended for GERD. However, the definition and the margin of “low-calorie, low-carbohydrate and fiber-enriched” remain unknown.
Adherence to specific dietary patterns
GERD has gradually become a global problem with the popularization of Western dietary patterns [31]. Switching dietary pattern to a low-FODMAP or Mediterranean diet may be beneficial for symptom relief. A low-FODMAP diet is characterized by low fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols [32]. A crossover RCT in 21 patients with overlapped GERD and irritable bowel syndrome demonstrated that a low-FODMAP diet significantly reduced postprandial GERD symptoms and the number of TLESRs [33]. However, Rivière etal. [32] found no significant difference between a 4-week low-FODMAP diet and the usual diet in relieving PPI-refractory GERD symptoms. The Mediterranean diet, characterized by plant-based food and low contents of saturated fat, has been reported as beneficial to health status [34]. In a cross-sectional study conducted in Albania, a Mediterranean diet was correlated with a decreased risk of GERD, irrespective of lifestyle factors and dietary habits [35].
Modification of dietary habits
In addition to dietary components and patterns, dietary habits in terms of the volume, speed, and timing of meals may also contribute to GERD symptoms. A high-volume meal might increase TLESRs and induce reflux [36]. A small controlled trial including 15 GERD patients showed that a high-volume meal significantly increased AET, the total number of reflux episodes, and symptoms as compared with a low-volume meal [37]. Rapid food intake was assumed to increase reflux as well [38]. However, two controlled trials showed no difference between fast- and slow-eating groups regarding either the number of reflux episodes or the severity of symptoms [39, 40]. Shorter dinner-to-bed time has been identified as a risk factor for GERD [41]. A crossover RCT further assessed its effects on GERD [42]. There were longer supine AET and more nocturnal reflux episodes in the late-meal group (2 h before going to bed) as compared with the early-meal group (6 h before going to bed).
On the basis of the available data, adherence to a low-FODMAP diet is recommended in patients with overlapped GERD–irritable bowel syndrome, while avoidance of a high-volume or late meal has shown benefits in patients with GERD symptoms. Further studies are needed to investigate the role of the Mediterranean diet in GERD and determine the definition of a high-volume meal.
Lifestyle modification
Several lifestyle factors have been identified as risk factors for GERD, including obesity and smoking. Besides, studies have shown the benefits of weight loss, tobacco cessation, sleeping with the head of the bed elevated, and proper exercise on GERD (Table 2). A prospective trial performed by Mehta etal. [43] showed a positive outcome with alterations in external lifestyle factors in GERD patients, with a 40% symptom prevention rate.
Table 2.
Prospective studies on lifestyle change for symptomatic GERD
| Author | Study design | Subject | Intervention | Follow-up duration | Outcome |
|---|---|---|---|---|---|
| Ness-Jensen etal. (2013) [46] | Cohort study | 29,610 GERD patients | – | – | Weight loss was dose-dependently associated with a reduction in GERD symptoms |
| Singh etal. (2013) [47] | Non-RCT | 332 overweight/obese subjects | Weight loss program | 6 months | Weight loss led to a decrease in waist circumference, body mass index, and GERD symptom scores |
| Ness-Jensen etal. (2013) [50] | Cohort study | 29,610 GERD patients | – | – | Tobacco cessation was associated with improvement in symptoms |
| Kohata etal. (2016) [51] | Non-RCT | 191 subjects | Smoking cessation | 1 year | A reduction in the prevalence of GERD* and overall improvement of symptoms was observed |
| Khan etal. (2012) [53] | Non-RCT | 24 patients with nocturnalreflux | Sleeping with head elevated by 20 cm | 7 days | Supine reflux time*** and symptom scores decreased** |
| Person etal. (2015) [55] | Crossover RCT | 20 healthy volunteers | Lying right-side down vs lying left-side down vs lying on a wedge vs lying flat | 4 nights | Lying left-side down led to the lowestacid exposure |
| Schuitenmaker etal. (2022) [56] | RCT | 100 patients with nocturnalGERD | Sleeping left-side down (n = 50) vs sham-controlled(n = 50) | 2 weeks | Lying left-side down reduced nocturnalreflux symptoms |
| Mehta etal. (2021) [43] | Cohort study | 42,955 women | – | 392,215 person-years | Adherence to moderate-to-vigorousactivity was associated with a decreased risk of GERD |
GERD, gastroesophageal reflux disease; RCT, randomized–controlled trial.
P < 0.05;
P ≤ 0.01;
P ≤ 0.001.
Weight loss
Obesity is associated with an increased risk of GERD. It was reported that the prevalence of GERD symptoms was 22% in overweight subjects [1]. The underlying mechanisms include elevated intra-abdominal and intra-gastric pressures, esophageal motility disorders, impaired esophageal mucosal barrier, and increased frequency of TLESRs [28, 44]. In a large population-based study of 10,545 women from the Nurses' Health Study, a dose-dependent association between increasing body mass index and severity of GERD symptoms was observed in both normal-weight and overweight women [45]. A genetic study further found a casual role of high body mass index in the development of GERD (OR 1.49, 95% CI 1.40–1.60) [28].
Weight loss was proven to be beneficial to prevent and treat GERD. Ness-Jensen etal. [46] prospectively enrolled 29,610 subjects and found that weight loss was not only associated with a reduction in symptoms, but also improved the treatment outcome of medical therapy. In an interventional trial, 332 overweight/obese subjects who received a structured weight loss program exhibited a significant decrease in the prevalence of GERD and symptom scores after 6 months [47]. The percentage of weight loss was positively correlated with symptom improvement (P < 0.05).
Tobacco cessation
Smoking worsens reflux symptoms. Tobacco consumption was shown to increase the risk of GERD by 1.12- to 1.70-fold in several population-based studies [21, 30, 48, 49], while smoking cessation could benefit GERD patients. In a cohort study of 29,610 subjects, tobacco cessation was associated with an improvement in GERD symptoms [50]. However, this association was only present among individuals using medication at least weekly or within the normal range of body mass index. Besides, the long-term effects of smoking cessation were confirmed by Kohata etal. [51]. Patients who quit smoking for a year had significant improvements in GERD symptoms and overall quality of life as compared with those who did not.
Bed head elevation during sleep
A reduction in nocturnal reflux was associated with a high quality of sleep [52]. In a clinical trial, patients with supine reflux had a significant reduction in supine AET and symptom score after sleeping with head elevated by 20 cm for 7 days [53].
In addition, the sleep position also plays a role. There was evidence that lying right-side down increased the incidence of TLESRs and induced more reflux episodes [54], while two RCTs demonstrated the superiority of lying left-side down [55, 56]. Lying left-side down was significantly associated with lower AET and decreased reflux episodes among healthy subjects, and a sham-controlled study including 100 patients with nocturnal GERD showed that avoidance of right lateral decubitus significantly reduced nocturnal symptoms and improved the sleep quality.
Proper physical exercise
Physical exercise seems to be a double-edged sword for GERD. Strenuous exercise may exacerbate GERD while moderate recreational exercise may have the opposite effect. Vigorous exercise could induce reflux and greater acid exposure in both healthy volunteers and athletes [57]. However, some cross-sectional studies have demonstrated that less physical exercise was a risk factor for GERD (the range of OR: 6.47–7.03), while moderate- or high-intensity physical exercise was associated with a decreased risk of GERD (the range of OR: 0.32–0.83) [30, 58, 59]. Moreover, prospective data showed that adherence to moderate-to-vigorous physical activity of ≥30 min a week was correlated with a decreased risk of GERD (the range of OR: 0.4– 0.9) [21, 43].
Taken together, lifestyle change, including weight loss, tobacco cessation, and sleeping with bed head elevation, is generally beneficial for symptomatic GERD patients. Although observational studies have found the association of proper exercise with a decreased risk of GERD, the degree of “proper” remains unclear. High-quality evidence on the effects of exercise on GERD patients is insufficient.
TCM
Herbal medicine
Herbal medicine, especially traditional Chinese herbal medicine, has long been used to treat GERD. As potential alternative options for GERD management, several TCM formulas have been shown non-inferior to Western medications in terms of symptom relief in RCTs, including JianpiQinghua granule, Wu chu yu tang, Tongjiang Granule, Modified Xiaochaihu Decoction, and Hewei Jiangni Decoction (Table 3) [60–64]. Among them, JianpiQinghua granule and Tongjiang Granule were superior to Western medications in symptom control. Meta-analyses also demonstrated that Wendan Decoction, Sini Zuojin Decoction, and Modified Banxia Xiexin Decoction had greater clinical efficacy as compared with Western medications [65–67]. From the prospective of TCM, the pathogenesis of GERD includes liver depression and spleen deficiency, and disharmony between the liver and stomach. Most of the formulas play a role in invigorating the spleen, regulating the liver, and harmonizing the stomach [68]. Evodiae fructus (Wu-Chu-Yu) and Coptidis Rhizoma (Huanglian) are the core ingredients of these formulas, which possibly target the anti-inflammatory pathway [69]. Although herbal formulas alone or in combination with Western medications have achieved certain efficacy in the treatment of GERD, their key components and protective mechanisms remain to be elucidated.
Table 3.
Prospective studies on traditional Chinese medicine for symptomatic GERD
| Author | Study design | Subject | Intervention | Follow-up duration | Outcome |
|---|---|---|---|---|---|
| Zhang etal. (2021) [63] | RCT | 204 GERD patients | Jianpi Qinghua granule + half-dose omeprazole (n = 98) vs omeprazole (n = 98) | 4 weeks | Jianpi Qinghua granule increased complete resolution rate* |
| Shih etal. (2019) [61] | RCT | 90 GERD patients | Wu chu yu tang (n = 40) vs omeprazole (n = 37) | 4 weeks | No difference in Reflux Disease Questionnaire and GERDQ was observed |
| Li etal. (2011) [60] | RCT | 120 non-erosive reflux diseasepatients | Tongjiang Granule (n = 57) vs mosapride citrate (n = 55) | 4 weeks | Tongjiang Granule increased effective rate** |
| Li etal. (2021) [62] | RCT | 288 GERD patients | Modified Xiaochaihu decoction (n = 39) vs omeprazole (n = 41) | 4 weeks | Similar symptom control (GERDQ) but improvement of esophageal motility (LESP, the percentage of IEM) on modifiedXiaochaihu decoction was observed |
| Li etal. (2022) [64] | RCT | 128 non-erosive reflux diseasepatients | Hewei Jiangni Decoction (n = 56) vs omeprazole (n = 53) | 8 weeks | Similar efficacy (GERDQ and patient-reported outcomes) was observed |
| Meng etal. (2016) [73] | RCT | 20 refractory GERD patients | ESO vs ESO + TEA vs ESO + sham TEA vs ESO + domperidone (n = 5, each group) | 4 weeks | A significant increase in LESP and reductionin weak acid reflux was only observed in ESO + TEA group |
| Hu etal. (2020) [74] | RCT | 30 GERD patients | TEA (n = 15) vs sham TEA (n = 15) | 30 min | Overall improvement of gastrointestinal symptoms (postprandial fullness and belching) on TEA was observed |
| Zhang etal. (2021) [75] | RCT | 30 GERD patients with IEM | TEA (n = 15) vs sham TEA (n = 15) | 4 weeks | Overall improvement of gastrointestinal symptoms (postprandial fullness and belching) and esophageal motility (LESP and distal contractile integral) on TEA was observed |
| Liu etal. (2019) [76] | RCT | 60 GERD patients | STEA (n = 45) vs sham TEA (n = 15) | 30 min | Improvement of esophageal motility (LESP and the percentage of IEM) and vagal activity (HF, LF, and LF/HF) on STEA was observed |
| Yu etal. (2019) [77] | RCT | 21 refractory GERD patients | TEA + diaphragmatic breathing therapy + ESO vs sham TEA + diaphragmaticbreathing therapy + ESO vs ESO (n = 7, each group) | 4 weeks | Improvement in reflux symptoms, LESP, and vagal activity (LF/LF + HF; HF/LF + HF) on TEA + diaphragmatic breathingtherapy + ESO was observed |
ESO, esomeprazole; GERD, gastroesophageal reflux disease; GERDQ, GERD questionnaire; HF, high-frequency; IEM, ineffective esophageal motility; LESP, lower esophageal sphincter pressure; LF, low-frequency; RCT, randomized–controlled trial; STEA, transcutaneous electrical acustimulation in synchronization with inspiration; TEA, transcutaneous electrical acustimulation; +, plus.
P < 0.05;
P ≤ 0.01.
Acupuncture
As a part of TCM, manual acupuncture and electroacupuncture have been reported effective in various gastrointestinal disorders, including GERD [70]. The major acupoints are ST36 (Zusanli) and PC6 (Neiguan). A meta-analysis showed that manual acupuncture/electroacupuncture plus Western medications led to significant symptom improvement, while manual acupuncture/electroacupuncture alone was associated with a lower recurrence rate as compared with Western medications [71]. However, manual acupuncture/electroacupuncture requires frequent visits to hospital and is performed under the supervision of professionals, which limits its wide use.
Recently, TEA, a non-invasive and needleless acupoint stimulation approach, has been applied for the treatment of GERD [72]. It can be performed by patients at home daily or even a few times daily. Meng etal. [73] concluded that those who received PPI plus TEA for 4 weeks had significantly higher lower esophageal sphincter pressure and symptom improvement than patients treated with PPI alone or PPI plus sham TEA. The potential mechanisms of TEA on GERD might be to enhance vagal activity, improve gastric accommodation, restore esophageal body motility, and normalize impaired gastric slow waves [74, 75].
TEA in synchronization with inspiration (STEA) was also shown to enhance vagal activity. During STEA, each electrical stimulus was in synchronization with inspiration. Similar to TEA, STEA had a significant impact on enhancing esophageal motility and relieving reflux symptoms in GERD patients [76, 77]. Though short-term benefits of TEA or STEA were proven in RCTs, further studies should focus on their long-term effects.
There are some limitations in studies of TCM. Most of the enrolled subjects were Chinese and the efficacy of TCM in other populations was unknown. In addition, the follow-up duration and sample size were inadequate in these studies. The mechanisms of herbal medicine are also unclear.
Brain–gut behavior therapy
GERD is associated with psychological distress, particularly anxiety and depression [78]. Poor mental state may result in reduced quality of life and treatment failure in GERD patients. Advances in behavior intervention science, especially BGBT, have enabled the improvement of these psychological co-morbidities. It targets specific cognitive, emotional, and behavioral factors and improves gastrointestinal symptoms [79]. Although the exact relationship between psychological distress and GERD is not well understood, some emerging BGBTs have shown benefits in GERD (Table 4).
Table 4.
Prospective studies on brain–gut behavior therapies for symptomatic GERD
| Author | Study design | Subject | Intervention | Follow-up duration | Outcome |
|---|---|---|---|---|---|
| Glasinovic etal. (2018) [81] | Non-RCT | 51 patients with pathological supragastric belching | Cognitive behavioral therapy | 8 weeks | The number of supragastric belching episodes***, the number of acid reflux episodes***, and acid exposure time** decreased |
| Eherer etal. (2012) [84] | RCT | 19 GERD patients | DB + PPI (n = 10) vs PPI (n = 9) | 4 weeks | There was a significant decrease in acid exposure time and improvement in quality of life on DB + PPI but not PPI alone |
| Sun etal. (2016) [82] | RCT | 40 GERD patients | DB + rabeprazole (n = 20) vs rabeprazole (n = 20) | 8 weeks | DB + rabeprazole significantly enhanced anti-reflux barrier (crural diaphragm tension and gastroesophageal junction pressure) compared with rabeprazole alone |
| Halland etal. (2021) [83] | RCT | 23 patients and 10 healthy volunteers | DB (n = 11 patients + 5 healthy volunteers) vs sham DB (remaining subjects) | 2 days | DB significantly decreased lower esophageal sphincter pressure***, the number of reflux episodes***,and postprandial acid exposure* |
| Chandran etal. (2019) [88] | Non-RCT | 120 GERD patients | Mindfulness-based stress reduction + PPI + lifestyle modification vs PPI + lifestyle modification | 8 weeks | Intervention with mindfulness-based stress reduction led to overall improvement of symptoms (GERD-Health-Related Quality of Life and symptom scores) |
DB, diaphragmatic breathing therapy; GERD, gastroesophageal reflux disease; PPI, proton-pump inhibitor; RCT, randomized–controlled trial; +, plus.
P < 0.05;
P ≤ 0.01;
P ≤ 0.001.
Cognitive behavioral therapy, one of the most well-tested BGBTs, has been used successfully in treating a range of digestive disorders. Patients who receive cognitive behavioral therapy learn ways to control their thoughts, behaviors, and physiologic responses, thus improving their physical and mental discomfort [79]. The effects of cognitive behavioral therapy have been investigated on excessive supragastric belching, which is a behavior disorder highly associated with GERD [80]. In an interventional trial of 39 patients with pathological supragastric belching, 8-week cognitive behavioral therapy significantly decreased the number of supragastric belching and acid reflux episodes, as well as AET [81].
Another promising BGBT is DB. Similar to TEA, DB helps to increase vagal activity and improve gastric and esophageal motility. Studies also showed that either acute (30 min) or chronic (8 weeks) DB could significantly enhance the function of the anti-reflux barrier [82, 83]. Furthermore, another RCT found a significant reduction in AET and GERD symptoms after 4 weeks of DB [84]. After 9 months of training, medication use was significantly reduced in patients.
Mindfulness-based therapy is rooted in being calm at the present moment via meditation and relaxation [79]. On mindfulness-based therapy, patients can reduce suffering pain and improve their moods [85]. There was evidence that patients with GERD exhibited higher scores of depression and anxiety, and impaired quality of life [86, 87]. Patients with GERD showed significant improvements in anxiety, depression, overall GERD symptoms, and quality of life after 8 weeks of mindfulness-based therapy [88].
Although there is strong evidence to support the application of BGBTs in a wide range of digestive disorders, the efficacy data on GERD are scarce. In addition to DB, cognitive behavioral therapy and mindfulness-based therapy hold promise for being useful adjuncts or alternatives in treating GERD.
Conclusions and recommendations
In the past decades, acid-suppressive therapy and surgical interventions have been the mainstay treatments for GERD, but they are followed by unsatisfying outcomes and adverse events. CAT may play a complementary or alternative role in treating GERD. In this review, we have concluded some evidence of CAT on GERD management.
In terms of dietary modification, avoidance of trigger foods or late meals is a complementary option for patients with GERD symptoms, while adherence to a low-FODMAP diet has shown benefits in patients with overlapped GERD–irritable bowel syndrome. In terms of lifestyle change, weight loss, smoking cessation, and sleeping with bed head elevation are beneficial for symptom control. As for potential alternatives, treatment outcomes of TCM and BGBTs are promising. However, high-quality RCTs with long-term follow-up and large sample sizes are needed.
In conclusion, complementary therapies, including aviodance of trigger foods or late meals, adherence to a low-FODMAP diet, weight loss, smoking cessation, and sleeping with bed head elevation, are recommended for GERD management, while the efficacy of alternative treatments, including TCM and BGBT, remains to be validated in the future.
Authors’ Contributions
D.J. and Q.Z. reviewed the literature, collected data, and drafted the manuscript; Y.X. conceived and designed the study and finalized the manuscript; X.J., S.C., N.T., and M.Z. revised the manuscript. All authors have read and approved the final version of the manuscript.
Acknowledgements
None.
Contributor Information
Dianxuan Jiang, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Qianjun Zhuang, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Xingyu Jia, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Songfeng Chen, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Niandi Tan, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Mengyu Zhang, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Yinglian Xiao, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Funding
This research was supported by the National Natural Science Foundation of China [grant numbers 82170577 and 81970479].
Conflict of Interest
All the authors have no conflict of interest to declare.
References
- 1. Eusebi LH, Ratnakumaran R, Yuan Y. et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018;67:430–40. [DOI] [PubMed] [Google Scholar]
- 2. Lata T, Trautman J, Townend P. et al. Current management of gastro-oesophageal reflux disease-treatment costs, safety profile, and effectiveness: a narrative review. Gastroenterol Rep (Oxf) 2023;11:goad008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Wahlqvist P, Karlsson M, Johnson D. et al. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther 2008;27:960–70. [DOI] [PubMed] [Google Scholar]
- 4. Hallan A, Bomme M, Hveem K. et al. Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study. Am J Gastroenterol 2015;110:393–400; quiz 401. [DOI] [PubMed] [Google Scholar]
- 5. Delshad SD, Almario CV, Chey WD. et al. Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology 2020;158:1250–61.e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Salvo EM, Ferko NC, Cash SB. et al. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther 2021;54:129–43. [DOI] [PubMed] [Google Scholar]
- 7. Maret-Ouda J, Wahlin K, El-Serag HB. et al. Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux. JAMA 2017;318:939–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Kushner BS, Awad MM, Mikami DJ. et al. Endoscopic treatments for GERD. Ann N Y Acad Sci 2020;1482:121–9. [DOI] [PubMed] [Google Scholar]
- 9. Chen S, Du F, Zhong C. et al. Gastroesophageal reflux disease: recent innovations in endoscopic assessment and treatment. Gastroenterol Rep (Oxf) 2021;9:383–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Ness-Jensen E, Hveem K, El-Serag H. et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2016;14:175–82.e1-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Xiao YL, Zhou LY, Hou XH. et al. ; Chinese Society of Gastroenterology. Chinese expert consensus on gastroesophageal reflux disease in 2020. J Dig Dis 2021;22:376–89. [DOI] [PubMed] [Google Scholar]
- 12. Katz PO, Dunbar KB, Schnoll-Sussman FH. et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117:27–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Tosetti C, Savarino E, Benedetto E. et al. ; Study Group for the Evaluation of GERD Triggering Foods. Elimination of dietary triggers is successful in treating symptoms of gastroesophageal reflux disease. Dig Dis Sci 2021;66:1565–71. [DOI] [PubMed] [Google Scholar]
- 14. El-Serag HB, Satia JA, Rabeneck L.. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 2005;54:11–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Colombo P, Mangano M, Bianchi PA. et al. Effect of increasing the fat content but not the energy load of a meal on gastro-oesophageal reflux and lower oesophageal sphincter motor function. Scand J Gastroenterol 2002;37:3–5.11843031 [Google Scholar]
- 16. Pehl C, Waizenhoefer A, Wendl B. et al. Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 1999;94:1192–6. [DOI] [PubMed] [Google Scholar]
- 17. Fox M, Barr C, Nolan S. et al. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol 2007;5:439–44. [DOI] [PubMed] [Google Scholar]
- 18. Piche T, Des Varannes SB, Sacher-Huvelin S. et al. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 2003;124:894–902. [DOI] [PubMed] [Google Scholar]
- 19. Pointer SD, Rickstrew J, Slaughter JC. et al. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women. Aliment Pharmacol Ther 2016;44:976–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Gu C, Olszewski T, King KL. et al. The effects of modifying amount and type of dietary carbohydrate on esophageal acid exposure time and esophageal reflux symptoms: a randomized controlled trial. Am J Gastroenterol 2022;117:1655–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Nilsson M, Johnsen R, Ye W. et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004;53:1730–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Morozov S, Isakov V, Konovalova M.. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World J Gastroenterol 2018;24:2291–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Aanen MC, Bredenoord AJ, Smout AJ.. Effect of dietary sodium chloride on gastro-oesophageal reflux: a randomized controlled trial. Scand J Gastroenterol 2006;41:1141–6. [DOI] [PubMed] [Google Scholar]
- 24. Song JH, Chung SJ, Lee JH. et al. Relationship between gastroesophageal reflux symptoms and dietary factors in Korea. JNeurogastroenterol Motil 2011;17:54–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Zhang M, Hou ZK, Huang ZB. et al. Dietary and lifestyle factors related to gastroesophageal reflux disease: a systematic review. Ther Clin Risk Manag 2021;17:305–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Johnson T, Gerson L, Hershcovici T. et al. Systematic review: the effects of carbonated beverages on gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2010;31:607–14. [DOI] [PubMed] [Google Scholar]
- 27. Chen Y, Chen C, Ouyang Z. et al. Prevalence and beverage-related risk factors of gastroesophageal reflux disease: an original study in Chinese college freshmen, a systemic review and meta-analysis. Neurogastroenterol Motil 2022;34:e14266. [DOI] [PubMed] [Google Scholar]
- 28. Yuan S, Larsson SC.. Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study. Eur J Epidemiol 2022;37:747–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Mehta RS, Song M, Staller K. et al. Association Between Beverage Intake and Incidence of Gastroesophageal Reflux Symptoms. Clin Gastroenterol Hepatol 2020;18:2226–33.e4. [DOI] [PubMed] [Google Scholar]
- 30. Yamamichi N, Mochizuki S, Asada-Hirayama I. et al. Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores. BMC Med 2012;10:45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Fitzgerald RC, Vaezi MF.. Esophageal Diseases. Gastroenterology 2018;154:263–6. [DOI] [PubMed] [Google Scholar]
- 32. Rivière P, Vauquelin B, Rolland E. et al. Low FODMAPs diet or usual dietary advice for the treatment of refractory gastroesophageal reflux disease: an open-labeled randomized trial. Neurogastroenterol Motil 2021;33:e14181. [DOI] [PubMed] [Google Scholar]
- 33. Patcharatrakul T, Linlawan S, Plaidum S. et al. The effect of rice vs. wheat ingestion on postprandial Gastroesophageal Reflux (GER) symptoms in patients with overlapping GERD-Irritable Bowel Syndrome (IBS). Foods 2021;11(1):26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Sofi F, Cesari F, Abbate R. et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008;337:a1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Mone I, Kraja B, Bregu A. et al. Adherence to a predominantly Mediterranean diet decreases the risk of gastroesophageal reflux disease: a cross-sectional study in a South Eastern European population. Dis Esophagus 2016;29:794–800. [DOI] [PubMed] [Google Scholar]
- 36. Emerenziani S, Zhang X, Blondeau K. et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol 2005;100:1251–6. [DOI] [PubMed] [Google Scholar]
- 37. Wu KL, Rayner CK, Chuah SK. et al. Effect of liquid meals with different volumes on gastroesophageal reflux disease. J Gastroenterol Hepatol 2014;29:469–73. [DOI] [PubMed] [Google Scholar]
- 38. Wildi SM, Tutuian R, Castell DO.. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol 2004;99:1645–51. [DOI] [PubMed] [Google Scholar]
- 39. Bor S, Bayrakci B, Erdogan A. et al. The influence of the speed of food intake on multichannel impedance in patients with gastro-oesophageal reflux disease. United European Gastroenterol J 2013;1:346–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Valitova ER, Bayrakçı B, Bor S.. The effect of the speed of eating on acid reflux and symptoms of patients with gastroesophageal reflux disease. Turk J Gastroenterol 2013;24:377–81. [PubMed] [Google Scholar]
- 41. Fujiwara Y, Machida A, Watanabe Y. et al. Association between dinner-to-bed time and gastro-esophageal reflux disease. Am J Gastroenterol 2005;100:2633–6. [DOI] [PubMed] [Google Scholar]
- 42. Piesman M, Hwang I, Maydonovitch C. et al. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol 2007;102:2128–34. [DOI] [PubMed] [Google Scholar]
- 43. Mehta RS, Nguyen LH, Ma W. et al. Association of diet and lifestyle with the risk of gastroesophageal reflux disease symptoms in US women. JAMA Intern Med 2021;181:552–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Paris S, Ekeanyanwu R, Jiang Y. et al. Obesity and its effects on the esophageal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2021;321:G335–g343. [DOI] [PubMed] [Google Scholar]
- 45. Jacobson BC, Somers SC, Fuchs CS. et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006;354:2340–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Ness-Jensen E, Lindam A, Lagergren J. et al. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol 2013;108:376–82. [DOI] [PubMed] [Google Scholar]
- 47. Singh M, Lee J, Gupta N. et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) 2013;21:284–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Nocon M, Labenz J, Willich SN.. Lifestyle factors and symptoms of gastro-oesophageal reflux -- a population-based study. Aliment Pharmacol Ther 2006;23:169–74. [DOI] [PubMed] [Google Scholar]
- 49. Zheng Z, Nordenstedt H, Pedersen NL. et al. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007;132:87–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Ness-Jensen E, Lindam A, Lagergren J. et al. Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study. Am J Gastroenterol 2014;109:171–7. [DOI] [PubMed] [Google Scholar]
- 51. Kohata Y, Fujiwara Y, Watanabe T. et al. Long-term benefits of smoking cessation on gastroesophageal reflux disease and health-related quality of life. PLoS One 2016;11:e0147860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Shibli F, Skeans J, Yamasaki T. et al. Nocturnal Gastroesophageal Reflux Disease (GERD) and sleep: an important relationship that is commonly overlooked. J Clin Gastroenterol 2020;54:663–74. [DOI] [PubMed] [Google Scholar]
- 53. Khan BA, Sodhi JS, Zargar SA. et al. Effect of bed head elevation during sleep in symptomatic patients of nocturnal gastroesophageal reflux. J Gastroenterol Hepatol 2012;27:1078–82. [DOI] [PubMed] [Google Scholar]
- 54. van Herwaarden MA, Katzka DA, Smout AJ. et al. Effect of different recumbent positions on postprandial gastroesophageal reflux in normal subjects. Am J Gastroenterol 2000;95:2731–6. [DOI] [PubMed] [Google Scholar]
- 55. Person E, Rife C, Freeman J. et al. A novel sleep positioning device reduces gastroesophageal reflux: a randomized controlled trial. J Clin Gastroenterol 2015;49:655–9. [DOI] [PubMed] [Google Scholar]
- 56. Schuitenmaker JM, Kuipers T, Oude Nijhuis RAB. et al. Sleep positional therapy for nocturnal gastroesophageal reflux: a double-blind, randomized, sham-controlled trial. Clin Gastroenterol Hepatol 2022;20:2753–62.e2. [DOI] [PubMed] [Google Scholar]
- 57. Jozkow P, Wasko-Czopnik D, Medras M. et al. Gastroesophageal reflux disease and physical activity. Sports Med 2006;36:385–91. [DOI] [PubMed] [Google Scholar]
- 58. Cela L, Kraja B, Hoti K. et al. Lifestyle characteristics and gastroesophageal reflux disease: a population-based study in Albania. Gastroenterol Res Pract 2013;2013:936792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Ahmed S, Jamil S, Shaikh H. et al. Effects of Life style factors on the symptoms of gastro esophageal reflux disease: a cross sectional study in a Pakistani population. Pak J Med Sci 2020;36:115–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Li BS, Li ZH, Tang XD. et al. A randomized, controlled, double-blinded and double-dummy trial of the effect of tongjiang granule on the nonerosive reflux disease of and Gan-Wei incoordination syndrome. Chin J Integr Med 2011;17:339–45. [DOI] [PubMed] [Google Scholar]
- 61. Shih YS, Tsai CH, Li TC. et al. Effect of wu chu yu tang on gastroesophageal reflux disease: randomized, double-blind, placebo-controlled trial. Phytomedicine 2019;56:118–25. [DOI] [PubMed] [Google Scholar]
- 62. Li Z, Tao L, Zhang SS. et al. Modified Xiaochaihu decoction for gastroesophageal reflux disease: a randomized double-simulation controlled trial. World J Gastroenterol 2021;27:4710–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Zhang J, Che H, Zhang B. et al. JianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: a multicenter, randomized, double-blind, double-dummy, noninferiority study. Phytomedicine 2021;88:153584. [DOI] [PubMed] [Google Scholar]
- 64. Li F, Yuan Y, Wu D. et al. Herbal medicine Hewei Jiangni decoction is noninferior to oral omeprazole for the treatment of nonerosivegastroesophageal reflux disease: a randomized, double-blind, and double-dummy controlled trail. Evid Based Complement Alternat Med 2022;2022:9647003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Dai Y, Zhang Y, Li D. et al. Efficacy and safety of modified Banxia Xiexin decoction (Pinellia decoction for draining the heart) for gastroesophageal reflux disease in adults: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2017;2017:9591319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Ling W, Huang Y, Xu JH. et al. Consistent efficacy of wendan decoction for the treatment of digestive reflux disorders. Am J Chin Med 2015;43:893–913. [DOI] [PubMed] [Google Scholar]
- 67. Li S, Huang M, Wu G. et al. Efficacy of Chinese herbal formula Sini Zuojin decoction in treating gastroesophageal reflux disease: clinical evidence and potential mechanisms. Front Pharmacol 2020;11:76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Dai YK, Wu YB, Wen H. et al. Different traditional herbal medicines for the treatment of gastroesophageal reflux disease in adults. Front Pharmacol 2020;11:884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Chen HY, Li Q, Zhou PP. et al. Mechanisms of Chinese medicine in gastroesophageal reflux disease treatment: data mining and systematic pharmacology study. Chin J Integr Med 2023;29:838–46. [DOI] [PubMed] [Google Scholar]
- 70. Yin J, Chen JD.. Gastrointestinal motility disorders and acupuncture. Auton Neurosci 2010;157:31–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Zhu J, Guo Y, Liu S. et al. Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis. Acupunct Med 2017;35:316–23. [DOI] [PubMed] [Google Scholar]
- 72. Chen JD, Yin J, Wei W.. Electrical therapies for gastrointestinal motility disorders. Expert Rev Gastroenterol Hepatol 2017;11:407–18. [DOI] [PubMed] [Google Scholar]
- 73. Meng LN, Chen S, Chen JD. et al. Effects of transcutaneous electrical acustimulation on refractory gastroesophageal reflux disease. Evid Based Complement Alternat Med 2016;2016:8246171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Hu Y, Zhang B, Shi X. et al. Ameliorating effects and autonomic mechanisms of transcutaneous electrical acustimulation in patients with gastroesophageal reflux disease. Neuromodulation 2020;23:1207–14. [DOI] [PubMed] [Google Scholar]
- 75. Zhang B, Hu Y, Shi X. et al. Integrative effects and vagal mechanisms of transcutaneous electrical acustimulation on gastroesophageal motility in patients with gastroesophageal reflux disease. Am J Gastroenterol 2021;116:1495–505. [DOI] [PubMed] [Google Scholar]
- 76. Liu Z, Lu D, Guo J. et al. Elevation of lower esophageal sphincter pressure with acute transcutaneous electrical acustimulation synchronized with inspiration. Neuromodulation 2019;22:586–92. [DOI] [PubMed] [Google Scholar]
- 77. Yu Y, Wei R, Liu Z. et al. Ameliorating effects of transcutaneous electrical acustimulation combined with deep breathing training on refractory gastroesophageal reflux disease mediated via the autonomic pathway. Neuromodulation 2019;22:751–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Jansson C, Nordenstedt H, Wallander MA. et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 2007;26:683–91. [DOI] [PubMed] [Google Scholar]
- 79. Keefer L, Ballou SK, Drossman DA. et al. A rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction. Gastroenterology 2022;162:300–15. [DOI] [PubMed] [Google Scholar]
- 80. Koukias N, Woodland P, Yazaki E. et al. Supragastric belching: prevalence and association with gastroesophageal reflux disease and esophageal hypomotility. J Neurogastroenterol Motil 2015;21:398–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Glasinovic E, Wynter E, Arguero J. et al. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux. Am J Gastroenterol 2018;113:539–47. [DOI] [PubMed] [Google Scholar]
- 82. Sun X, Shang W, Wang Z. et al. Short-term and long-term effect of diaphragm biofeedback training in gastroesophageal reflux disease: an open-label, pilot, randomized trial. Dis Esophagus 2016;29:829–36. [DOI] [PubMed] [Google Scholar]
- 83. Halland M, Bharucha AE, Crowell MD. et al. Effects of diaphragmatic breathing on the pathophysiology and treatment of upright gastroesophageal reflux: a randomized controlled trial. Am J Gastroenterol 2021;116:86–94. [DOI] [PubMed] [Google Scholar]
- 84. Eherer AJ, Netolitzky F, Högenauer C. et al. Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study. Am J Gastroenterol 2012;107:372–8. [DOI] [PubMed] [Google Scholar]
- 85. Ballou S, Keefer L.. Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clin Transl Gastroenterol 2017;8:e214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Lee YC, Wang HP, Chiu HM. et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol 2006;21:798–804. [DOI] [PubMed] [Google Scholar]
- 87. Yang XJ, Jiang HM, Hou XH. et al. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol 2015;21:4302–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Chandran S, Raman R, Kishor M. et al. The effectiveness of mindfulness meditation in relief of symptoms of depression and quality of life in patients with gastroesophageal reflux disease. Indian J Gastroenterol 2019;38:29–38. [DOI] [PubMed] [Google Scholar]
